Cite
HARVARD Citation
Nakamura, K. et al. (2022). A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19. Clinical and translational science. 15 (11), pp. 2697-2708. [Online].